| Christopher James Hebert, | |
|
325 9th Ave, Seattle, WA 98104-2420 | |
| (206) 520-5000 | |
| Not Available |
| Full Name | Christopher James Hebert |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295115426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD60953927 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harborview Medical Center | Seattle, WA | Hospital |
| University Of Washington Medical Ctr | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
The discovery of an "Achilles heel" in a type of gut bacteria that causes intestinal inflammation in patients with Crohn's disease may lead to more targeted therapies for the difficult to treat disease, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
› Verified 6 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
The discovery of an "Achilles heel" in a type of gut bacteria that causes intestinal inflammation in patients with Crohn's disease may lead to more targeted therapies for the difficult to treat disease, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher James Hebert, Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Christopher James Hebert, 325 9th Ave, Seattle, WA 98104-2420 Ph: (206) 520-5000 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
The discovery of an "Achilles heel" in a type of gut bacteria that causes intestinal inflammation in patients with Crohn's disease may lead to more targeted therapies for the difficult to treat disease, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
› Verified 6 days ago
Sasha Kaiser, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Kristopher Allen Hendershot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Lauren Kristen Whiteside, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-8464 | |
Brenda Park, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-5762 Fax: 814-537-5677 | |
Rhadika Mccormick Souza, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-583-6433 Fax: 206-583-6583 | |
Eleanor Ganz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-598-4955 | |
Dr. Gary H. Somers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-1765 |